Vytorin Cancer Risk

Editors at the New England Journal of Medicine have warned that it's impossible to rule out a link between the cholesterol-lowering drug Vytorin and cancer. The connection came to light in July from 3 studies which were looking at whether the drug prevents deaths from heart attacks and strokes. The data revealed that patients taking Vytorin appear to have at least a 40% higher risk of dying from cancer than those taking a placebo.